First Manhattan’s Sanara MedTech SMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,700
Closed -$69.9K 1486
2023
Q4
$69.9K Hold
1,700
﹤0.01% 811
2023
Q3
$52.9K Hold
1,700
﹤0.01% 858
2023
Q2
$68.2K Hold
1,700
﹤0.01% 834
2023
Q1
$70.1K Hold
1,700
﹤0.01% 863
2022
Q4
$77.3K Hold
1,700
﹤0.01% 868
2022
Q3
$47K Buy
+1,700
New +$47.6K ﹤0.01% 942

Other funds holding SMTI

First Manhattan's SMTI Position: Q1 2024 in Review

First Manhattan sold out of Sanara MedTech (SMTI) in Q1 2024, closing a stake of 1,700 shares — an estimated $69.9K sold.

First Manhattan first reported a position in SMTI in Q3 2022 and held it in 6 quarters. The position peaked at $77.3K in Q4 2022. 43 funds tracked by Wall St. Rank hold SMTI as of Q1 2024.

  • First Manhattan reported no remaining Sanara MedTech position as of Q1 2024 after selling out during the quarter.
  • First Manhattan sold 1,700 Sanara MedTech shares in Q1 2024, an estimated $69.9K.
  • First Manhattan first reported a position in Sanara MedTech in Q3 2022 and held it in 6 quarters.
  • First Manhattan's Sanara MedTech position peaked at $77.3K in Q4 2022.
  • 43 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2024.

Based on First Manhattan's 13F filing for Q1 2024, filed 15 May 2024.